ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: Proteoglycans are one of the active ingredients of great importance in Sarcandra glabra. The biological activities of proteoglycans extracted from Sarcandra glabra including suppressing tumor growth and antioxidant activity were studied. However, raw materials from different regions may cause differences in the activity of natural extracts, especially for bioactive biomacromolecules. Conventional identification of S.glabra cannot accurately reflect the distinguishing relationship between internal components and the pharmacological activity. The identification of biologically active structures was obtained by constructing multiple fingerprint and spectrum-effect relationship. AIM OF THE STUDY: To evaluate the bioactive structural basis of proteoglycans from S.glabra based on spectrum-effect relationship and chemometric methods. MATERIALS AND METHODS: Multiple fingerprinting including HPSEC, PMP-HPLC, and FT-IR of proteoglycans was established from 18 batches of samples based on the structural characteristics. Both antitumor activity and antioxidant activity were determined. Mathematical analysis was used to analyze the spectrum-effect relationship. RESULTS: PCA results showed monosaccharides including Xly, Rha, and GlcA, carboxyl group in acidic sugars, peptide bond in proteins, and methylene groups could be used as markers for distinguishing the samples from different sources. The results of the spectrum-effect relationship analysis indicated that the bioactive markers of inhibitory activity on MG63 and U2OS cells by PLS-DA were related to GlcA, Xyl, Fuc, ß-glycosidic bonds, peptide linkage, and methylene groups. Markers composing monosaccharide for antioxidant activity were Xyl, GlcA, and GlcN. Meanwhile, the group markers were pyranose ring, carboxyl group, peptide linkage, and methylene structure. CONCLUSIONS: The material basis that affects the pharmacological efficacy could be found according to the spectrum-effect relationship analysis. This study could lay a foundation for further exploring the relationship between structural characteristics and pharmacodynamics of macromolecular glycoconjugates in Traditional Chinese Medicine.
Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Antioxidants/pharmacology , Cell Proliferation/drug effects , Magnoliopsida , Neoplasms/drug therapy , Plant Extracts/pharmacology , Proteoglycans/pharmacology , Spectroscopy, Fourier Transform Infrared , Antineoplastic Agents, Phytogenic/isolation & purification , Antioxidants/isolation & purification , Cell Line, Tumor , Dose-Response Relationship, Drug , Humans , Inhibitory Concentration 50 , Magnoliopsida/chemistry , Molecular Structure , Molecular Weight , Neoplasms/pathology , Plant Extracts/isolation & purification , Proteoglycans/isolation & purification , Structure-Activity RelationshipABSTRACT
Corbicula fluminea (Asian clam), a freshwater bivalve mollusk, has been consumed in China for centuries as a health food and traditional Chinese medicine for treating liver diseases and alcoholism. This study aimed to evaluate the hepato-protective effects and potential mechanisms of a proteoglycan (PSP) from C. fluminea on alcohol-induced liver injury in mice. Results showed that PSP pretreatment significantly antagonized the increases in serum alanine aminotransferase, aspartate aminotransferase, triacylglycerides, and hepatic malondialdehyde levels; elevated the antioxidant enzyme activities and hepatic glutathione levels; and suppressed the levels of hepatic inflammatory cytokines in alcohol-induced liver injury in mice (P < 0.05). Histopathological observation further revealed the potential hepato-protective effect of PSP against alcohol damage. Particularly, PSP pretreatment resulted in significantly decreased expression of cytochrome P450 2e1 (CYP2E1) while significantly upregulating the expression of hemeoxygenase-1 (HO-1) (P < 0.05). These results suggested that PSP could protect the liver from hepatocyte injury induced by alcohol possibly by alleviating hepatic lipid metabolism, elevating antioxidant-enzyme activity, suppressing the immune inflammatory response, and reversing the expression levels of CYP2E1 and HO-1. Therefore, PSP may be developed as a food supplement that can be used to prevent liver diseases.
Subject(s)
Chemical and Drug Induced Liver Injury, Chronic/drug therapy , Corbicula/chemistry , Liver/drug effects , Proteoglycans/isolation & purification , Proteoglycans/pharmacology , Alanine Transaminase/blood , Animals , Antioxidants , Aspartate Aminotransferases/blood , Chemical and Drug Induced Liver Injury, Chronic/pathology , Cytochrome P-450 CYP2E1/metabolism , Cytokines/metabolism , Disease Models, Animal , Ethanol/adverse effects , Glutathione/metabolism , Heme Oxygenase-1/metabolism , Liver/pathology , Male , Malondialdehyde/metabolism , Medicine, Chinese Traditional , Mice , Protective Agents/isolation & purification , Protective Agents/pharmacologyABSTRACT
Acute respiratory distress syndrome is a severe form of respiratory failure, occurring in up to 20% of patients admitted to the intensive care unit with sepsis. Dysregulated leukocyte diapedesis is a major contributor to acute respiratory distress syndrome. Endocan is a circulating proteoglycan that binds to the leukocyte integrin leukocyte functional antigen-1 and blocks its interaction with its endothelial ligand, ICAM-1. The objective of this study was to evaluate the role of endocan in the control of acute lung inflammation. In vitro, endocan inhibited human leukocyte transendothelial migration as well as ICAM-1-dependent migration but had a very mild effect on ICAM-1-dependent adhesion. Endocan also acted as an inhibitor of transendothelial migration of mouse leukocytes. The effect of systemic administration of recombinant human endocan was assessed in a model of acute lung inflammation in BALB/c mice. Treatment with endocan 1 h after intratracheal LPS challenge reduced the alveolar inflammatory response, diminished histological features of acute lung injury, and improved respiratory function. These results highlight the anti-inflammatory role of human endocan and its protective effect against acute lung injury.NEW & NOTEWORTHY We show here that endocan inhibits ICAM-1-dependent human leukocyte transendothelial migration and ICAM-1-dependent adhesion. We also found that in BALB/c mice with tracheal LPS-induced acute lung injury treatment with recombinant human endocan reduces lung inflammation, notably through reduction of neutrophilic recruitment, and restores normal lung function. These results confirm the hypothesis that human endocan may have a protective effect against acute lung inflammation.
Subject(s)
Acute Lung Injury/drug therapy , Leukocytes/drug effects , Neoplasm Proteins/therapeutic use , Proteoglycans/therapeutic use , Transendothelial and Transepithelial Migration/drug effects , Animals , Capillary Permeability/drug effects , Cell Adhesion/drug effects , Cell Movement/drug effects , Drug Evaluation, Preclinical , HEK293 Cells , Humans , Intercellular Adhesion Molecule-1/metabolism , Lipopolysaccharides , Male , Mice, Inbred BALB C , Neoplasm Proteins/isolation & purification , Neoplasm Proteins/pharmacology , Proteoglycans/isolation & purification , Proteoglycans/pharmacology , Respiratory Rate/drug effectsABSTRACT
OBJECTIVE: This study is to investigate the immunomodulatory effects of the herbal formula of astragalus polysaccharide (APS) and polysaccharopeptide (PSP) in mouse models of immunosuppression and lung cancer. METHODS: Immune parameters were recorded for these model mice. Peripheral white blood cells (WBC) were detected with the automatic blood cell analyzer. Spleen and thymus indices, and tumor inhibition ratio were obtained. Percentage of peripheral blood CD4+ and CD8+ T lymphocytes were detected by flow cytometry. Serum levels of Th1 (IL-2, TNF, and IFN-γ), Th2 (IL-4, IL-6, and IL-10), and Th17 (IL-17A) were detected with the BD cytometric bead array (CBA) mouseTh1/Th2/Th17 cytokine kit. RESULTS: Compared with the NS group, the PSP and APS herbal formula significantly improved the WBC, thymus index, spleen index, CD4+/CD8+ ratio, TNF, IFN-γ, IL-2, andIL-17Ainimmunosuppressivemice and lung cancer mice (P<0. 05). On the contrary, IL-10 was relatively low in the PSP+APS herbal formula group (P<0. 05). Besides, the PSP+APS herbal formula group induced comparable tumor inhibiting effect with the AMD group (23.3% and 24.1%, respectively). CONCLUSION: The PSP+APS herbal formula have immunomodulatory effects and anti-tumor activity in mice with of lung cancer.
Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Astragalus Plant/chemistry , Carcinoma, Lewis Lung/drug therapy , Immunologic Factors/pharmacology , Polysaccharides/pharmacology , Proteoglycans/pharmacology , Administration, Oral , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Carcinoma, Lewis Lung/immunology , Carcinoma, Lewis Lung/pathology , Cytokines/biosynthesis , Cytokines/immunology , Doxorubicin/pharmacology , Female , Immunologic Factors/isolation & purification , Injections, Intraperitoneal , Mice , Mice, Inbred C57BL , Polysaccharides/isolation & purification , Proteoglycans/isolation & purification , Spleen/drug effects , Spleen/immunology , Spleen/pathology , Th1 Cells/drug effects , Th1 Cells/immunology , Th1 Cells/pathology , Th1-Th2 Balance/drug effects , Th17 Cells/drug effects , Th17 Cells/immunology , Th17 Cells/pathology , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/pathology , Thymus Gland/drug effects , Thymus Gland/immunology , Thymus Gland/pathologyABSTRACT
Insulin resistance caused by the overexpression of protein tyrosine phosphatase 1 B (PTP1B) as well as the dephosphorylation of its target is one of the main causes of type 2 diabetes (T2D). A newly discovered proteoglycan, Fudan-Yueyang Ganoderma lucidum (FYGL) extracted from Ganoderma lucidum, was first reported to be capable of competitively inhibiting PTP1B activity in vitro in our previous work. In the present study, we sought to reveal the mechanism of PTP1B inhibition by FYGL at the animal and cellular levels. We found that FYGL can decrease blood glucose, reduce body weight and ameliorate insulin resistance in ob/ob mice. Decrease of PTP1B expression and increase of the phosphorylation of PTP1B targets in the insulin signaling pathway of skeletal muscles were observed. In order to clearly reveal the underlying mechanism of the hypoglycemic effect caused by FYGL, we further investigated the effects of FYGL on the PTP1B-involved insulin signaling pathway in rat myoblast L6 cells. We demonstrated that FYGL had excellent cell permeability by using a confocal laser scanning microscope and a flow cytometer. We found that FYGL had a positive effect on insulin-stimulated glucose uptake by using the 2-deoxyglucose (2-DG) method. FYGL could inhibit PTP1B expression at the mRNA level, phosphorylating insulin receptor substrate-1 (IRS1), as well as activating phosphatidylinositol-3 kinase (PI3K) and protein kinase B (Akt). Finally, FYGL increased the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and consequently up-regulated the expression of glucose transporter type 4 (GLUT4), promoting GLUT4 transportation to the plasma membrane in PTP1B-transfected L6 cells. Our study provides theoretical evidence for FYGL to be potentially used in T2D management.
Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Glucose Transporter Type 4/metabolism , Insulin Receptor Substrate Proteins/metabolism , Insulin Resistance , Intracellular Signaling Peptides and Proteins/administration & dosage , Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonists & inhibitors , Reishi/chemistry , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/metabolism , Glucose Transporter Type 4/genetics , Humans , Insulin/metabolism , Insulin Receptor Substrate Proteins/genetics , Intracellular Signaling Peptides and Proteins/chemistry , Intracellular Signaling Peptides and Proteins/isolation & purification , Mice , Mice, Inbred C57BL , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Proteoglycans/administration & dosage , Proteoglycans/chemistry , Proteoglycans/isolation & purification , Rats , Signal Transduction/drug effectsABSTRACT
Glycosaminoglycans (GAGs) are natural, linear and negatively charged heteropolysaccharides which are incident in every mammalian tissue. They consist of repeating disaccharide units, which are composed of either sulfated or non-sulfated monosaccharides. Depending on tissue types, GAGs exhibit structural heterogeneity such as the position and degree of sulfation or within their disaccharide units composition being heparin, heparan sulfate, chondroitine sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. They are covalently linked to a core protein (proteoglycans) or as free chains (hyaluronan). GAGs affect cell properties and functions either by direct interaction with cell receptors or by sequestration of growth factors. These evidences of divert biological roles of GAGs make their characterization at cell and tissue levels of importance. Thus, non-invasive techniques are interesting to investigate, to qualitatively and quantitatively characterize GAGs in vitro in order to use them as diagnostic biomarkers and/or as therapeutic targets in several human diseases including cancer. Infrared and Raman microspectroscopies and imaging are sensitive enough to differentiate and classify GAG types and subtypes in spite of their close molecular structures. Spectroscopic markers characteristic of reference GAG molecules were identified. Beyond these investigations of the standard GAG spectral signature, infrared and Raman spectral signatures of GAG were searched in complex biological systems like cells. The aim of the present review is to describe the implementation of these complementary vibrational spectroscopy techniques, and to discuss their potentials, advantages and disadvantages for GAG analysis. In addition, this review presents new data as we show for the first time GAG infrared and Raman spectral signatures from conditioned media and live cells, respectively.
Subject(s)
Dermatan Sulfate/chemistry , Heparitin Sulfate/chemistry , Hyaluronic Acid/chemistry , Keratan Sulfate/chemistry , Proteoglycans/chemistry , Spectrum Analysis, Raman/methods , Animals , CHO Cells , Cricetulus , Culture Media, Conditioned/chemistry , Dermatan Sulfate/isolation & purification , Dermatan Sulfate/metabolism , Disaccharides/chemistry , Heparitin Sulfate/isolation & purification , Heparitin Sulfate/metabolism , Humans , Hyaluronic Acid/isolation & purification , Hyaluronic Acid/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Keratan Sulfate/isolation & purification , Keratan Sulfate/metabolism , Protein Binding , Proteoglycans/isolation & purification , Proteoglycans/metabolism , Receptors, Cell Surface/metabolism , Spectrum Analysis, Raman/instrumentation , Sulfates/chemistryABSTRACT
A filamentous fungus strain OU5 was isolated from a soil sample for its ability to produce rich exopolymers (EPS), with high flocculation capability towards kaolin suspension and swine wastewater, at low-carbon source conditions. EPS from strain OU5 was extracted and characterized to determine its flocculating behavior and active constituents involved in the flocculation. Strain OU5 was identified as Talaromyces trachyspermus by 18S rDNA-ITS gene sequencing and morphological observation. The extracted EPS was a novel proteoglycan (designated as BF-OU5) composed of 84.6% (w/w) polysaccharides and 15.2% (w/w) proteins. The enzymatic digestion tests revealed that the polysaccharides in BF-OU5, composed of 67% glucose, 16.4% mannose, 8.6% xylose and 8% galactose, contributed to 99.7% of flocculating capacity and were the major active ingredients in the flocculation. By contrast, the proteins in BF-OU5 only had minor roles in the flocculation. The presence of hydroxyl, amide, carboxyl and methoxyl functional groups in BF-OU5, and the high molecular weight (1.053 × 10(5)-2.970 × 10(5) Da) as well as the structure of a spherical conformation with inner pores and channels made of cross-linked netted textures contributed to the flocculation. A dosage of 20 mg/l BF-OU5 initiated more than 92.5% of flocculating efficiency towards kaolin suspension without any added coagulants; its flocculability was stable over a wide range of pH (4.0-8.0) and temperature (20°C-100°C). Treatment of swine wastewater using BF-OU5 achieved 52.1% flocculating removal for chemical oxygen demand, 39.7% for Kjeldahl nitrogen, 18.6% for NH4(+)-N, 21.5% for total phosphorus, and 75% for turbidity.
Subject(s)
Proteoglycans/chemistry , Proteoglycans/metabolism , Talaromyces/metabolism , Animals , Carbon/metabolism , Flocculation/drug effects , Galactose/analysis , Glucose/analysis , Hydrogen-Ion Concentration , Kaolin/pharmacology , Mannose/analysis , Nitrogen/metabolism , Oxygen/metabolism , Phosphorus/metabolism , Proteoglycans/biosynthesis , Proteoglycans/isolation & purification , Swine , Talaromyces/chemistry , Talaromyces/genetics , Talaromyces/isolation & purification , Temperature , Wastewater/chemistry , Xylose/analysisABSTRACT
Protein tyrosine phosphatase 1B (PTP1B) is implicated in the negative regulation of the insulin signalling pathway by dephosphorylating the insulin receptor (IR) and IR substrates. Ganoderma lucidum has traditionally been used for the treatment of diabetes in Chinese medicine; however, its anti-diabetic potency and mechanism in vivo is still unclear. Our previously published study reported a novel proteoglycan PTP1B inhibitor, named Fudan-Yueyang-Ganoderma lucidum (FYGL) from G. lucidum, with a half-maximal inhibitory concentration (IC50) value of 5·12 (sem 0·05) µg/ml, a protein:polyglycan ratio of 17:77 and 78 % glucose in polysaccharide, and dominant amino acid residues of aspartic acid, glycine, glutamic acid, alanine, serine and threonine in protein. FYGL is capable of decreasing plasma glucose in streptozotocin-induced diabetic mice with a high safety of median lethal dose (LD50) of 6 g/kg. In the present study, C57BL/6 db/db diabetic mice were trialed further using FYGL as well as metformin for comparison. Oral treatment with FYGL in db/db diabetic mice for 4 weeks significantly (P < 0·01 or 0·05) decreased the fasting plasma glucose level, serum insulin concentration and the homeostasis model assessment of insulin resistance. FYGL also controlled the biochemistry indices relative to type 2 diabetes-accompanied lipidaemic disorders. Pharmacology research suggests that FYGL decreases the plasma glucose level by the mechanism of inhibiting PTP1B expression and activity, consequently, regulating the tyrosine phosphorylation level of the IR ß-subunit and the level of hepatic glycogen, thus resulting in the improvement of insulin sensitivity. Therefore, FYGL is promising as an insulin sensitiser for the therapy of type 2 diabetes and accompanied dyslipidaemia.
Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Enzyme Inhibitors/therapeutic use , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/therapeutic use , Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonists & inhibitors , Proteoglycans/therapeutic use , Reishi/chemistry , Animals , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/physiopathology , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/isolation & purification , Drugs, Chinese Herbal/therapeutic use , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/isolation & purification , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/isolation & purification , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/isolation & purification , Insulin Resistance , Lipid Metabolism/drug effects , Liver/drug effects , Liver/enzymology , Liver/metabolism , Liver Glycogen/metabolism , Male , Mice , Mice, Mutant Strains , Organ Specificity , Phosphorylation/drug effects , Protein Processing, Post-Translational/drug effects , Protein Subunits/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Proteoglycans/administration & dosage , Proteoglycans/isolation & purification , Receptor, Insulin/metabolismABSTRACT
Polysaccharide peptide (PSP), isolated from COV-1 strain of Coriolus versicolor, is commonly used as an adjunct in cancer chemotherapy or health supplement in China. Previous studies have shown that PSP decreased antipyrine clearance and inhibited rat CYP2C11-mediated tolbutamide 4-hydroxylation and in human CYP2C9. In this study, the effects of the water extractable fraction of PSP on the metabolism of model CYP1A2, CYP2D6, CYP2E1 and CYP3A4 probe substrates were investigated in pooled human liver microsomes. PSP (1.25-20µM) dose-dependently decreased CYP1A2-mediated metabolism of phenacetin to paracetamol (IC(50) 19.7µM) and CYP3A4-mediated metabolism of testosterone to 6ß-hydroxytestosterone (IC(20) 7.06µM). Enzyme kinetics studies showed the inhibition of CYP1A2 activity was competitive and concentration-dependent (K(i)=18.4µM). Inhibition of testosterone to 6ß-hydroxytestosterone was also competitive and concentration-dependent (K(i)=31.8µM). Metabolism of dextromethorphan to dextrorphan (CYP2D6-mediated) and chlorzoxazone to 6-hydroxychlorzoxazone (CYP2E1-mediated) was only minimally inhibited by PSP, with IC(20) values at 15.6µM and 11.9µM, respectively. This study demonstrated that PSP competitively inhibited the CYP1A2- and CYP3A4-mediated metabolism of model probe substrates in human liver microsomes in vitro. The relatively high K(i) values for CYP1A2 and CYP3A4 would suggest a low potential for PSP to cause herb-drug interaction related to these CYP isoforms.
Subject(s)
Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors , Coriolaceae/chemistry , Enzyme Inhibitors/pharmacology , Microsomes, Liver/drug effects , Proteoglycans/pharmacology , Aryl Hydrocarbon Hydroxylases/metabolism , Cytochrome P-450 CYP1A2/metabolism , Cytochrome P-450 CYP1A2 Inhibitors , Cytochrome P-450 CYP2D6/metabolism , Cytochrome P-450 CYP2D6 Inhibitors , Cytochrome P-450 CYP2E1/metabolism , Cytochrome P-450 CYP2E1 Inhibitors , Cytochrome P-450 CYP3A/metabolism , Cytochrome P-450 CYP3A Inhibitors , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Humans , Kinetics , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , Mycelium/chemistry , Proteoglycans/chemistry , Proteoglycans/isolation & purificationABSTRACT
An algal extracellular biopolymer (over 8.5 × 10(5)Da) composed of carbohydrates (52%) and protein (â¼13%) has been isolated from a red alga Rhodella grisea growing in natural conditions by concentration of water medium, alcohol precipitation, dialysis and freeze-drying. This mucilagineous biopolymer contained xylose and its 3-O- and 4-O-methyl derivatives (â¼63%), galactose (â¼12%), glucuronic acid (11-12%), glucose (â¼5%), rhamnose (â¼4%), fucose (â¼3-4%) and low content of others accompaning sugars. When tested on the citric acid-induced cough and reactivity of airways smooth muscle in vivo in the test system guinea pigs, this biopolymer assigned a significant cough suppressing effect. The reactivity of airways smooth muscle was not affected indicating that expectoration effect was not suppressed by biopolymer application, which is important from the pharmacological point of view.
Subject(s)
Biopolymers/administration & dosage , Bronchial Hyperreactivity/prevention & control , Cough/drug therapy , Plant Extracts/administration & dosage , Proteoglycans/administration & dosage , Respiratory System/drug effects , Rhodophyta/chemistry , Administration, Inhalation , Administration, Oral , Airway Resistance/drug effects , Animals , Antitussive Agents , Biopolymers/chemistry , Biopolymers/isolation & purification , Citric Acid/adverse effects , Cough/chemically induced , Cough/physiopathology , Freeze Drying , Glucuronic Acid/chemistry , Guinea Pigs , Male , Monosaccharides/chemistry , Muscle, Smooth/drug effects , Muscle, Smooth/physiopathology , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plethysmography , Proteoglycans/chemistry , Proteoglycans/isolation & purification , Reflex/drug effects , Reflex/physiology , Respiratory System/physiopathology , ViscosityABSTRACT
The immunomodulatory effect of Ganoderma lucidum immunomodulating substance (GLIS) on macrophages has been investigated as part of on-going research into the anti-cancer properties of Ganoderma lucidum. Proliferation of bone marrow macrophages (BMMs) was enhanced by GLIS in a dose-dependent manner. Microscopic examination revealed that numerous GLIS-treated RAW264.7 macrophages were enlarged and formed pseudopodia. Exposure of RAW264.7 macrophages to GLIS resulted in significant increases in NO production, induction of cellular respiratory burst activity, and increased levels of IL-1beta, IL-12p35 and IL-12p40 gene expression. Our data indicate that GLIS activates the immune system by modulating cytokine production.
Subject(s)
Immunologic Factors/pharmacology , Macrophages/drug effects , Proteoglycans/pharmacology , Reishi/chemistry , Animals , Cell Line , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Gene Expression/drug effects , Immunologic Factors/immunology , Immunologic Factors/isolation & purification , Interleukin-12 Subunit p35/genetics , Interleukin-12 Subunit p40/genetics , Interleukin-1beta/genetics , L Cells , Luminescent Measurements/methods , Luminol/metabolism , Macrophages/cytology , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Nitric Oxide/metabolism , Polysaccharides/pharmacology , Proteoglycans/immunology , Proteoglycans/isolation & purification , RNA, Messenger/genetics , RNA, Messenger/metabolism , Respiratory Burst/drug effects , Respiratory Burst/immunology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
GL-PP-3A, an active polysaccharide peptide, was isolated and purified from Ganoderma lucidum, and then its structure was analyzed. Crude polysaccharide peptides were extracted from Ganoderma lucidum with hot water, precipitated with ethanol and then dialyzed from Ganoderma lucidum. Subsequently GL-PP-3A was isolated and purified from the crude polysaccharide peptides by fractional precipitation and chromatography of Bio-Gel P-10 column. The repetitive unit of GL-PP-3A was analyzed by high performance gel permeation chromatography (HPGPC), monosaccharide composition and methylation analysis, 1H NMR and 13C NMR. GL-PP-3A is a heteropolysaccharide which is composed mainly of glucose (Glc), and also contains saccharide residues such as rhamnose (Rha), xylose (Xyl), mannose (Man) and galactose (Gal) and 17 kinds of amino acids. Its weight-average molecular weight (Mw) and number-average molecular weight (Mn) were 1.7 x 10(4) and 1.1 x 10(4), respectively, with the ratio of Mw/Mn ( molecular weight distribution) being of 1.49. Its backbone chain is composed of 1,6-linked beta-D-Glcp and 1,3-liked beta-D-Glcp at a ratio of 2:1. Some of 1,6-linked glucose residuals of the backbone chain are substituted at 2-0 or 3-0, and there are 1 to 3 1,6-linked beta-D-Galp or 1,3-linked alpha-D-Manp in the branched chains, the nonreducing ends of which consist mainly of beta-D-Glcp and a few Rha.
Subject(s)
Polysaccharides/chemistry , Polysaccharides/isolation & purification , Proteoglycans/chemistry , Proteoglycans/isolation & purification , Reishi/chemistry , Amino Acids/analysis , Chromatography, High Pressure Liquid , Glucose/analysis , Magnetic Resonance Spectroscopy , Molecular Weight , Plants, Medicinal/chemistry , Rhamnose/analysis , Spectrophotometry, UltravioletABSTRACT
Pleurotus ostreatus is one of the widely cultivated edible mushrooms. Water-soluble proteoglycan fractions from P. ostreatus mycelia were purified by alcohol-precipitation, ion exchange and followed by gel permeation (Sephadex G-100) chromatography. Three neutral fractions were found, which had polysaccharide to protein ratios 14.2, 26.4 and 18.3, respectively. These fractions were tested for in vitro and in vivo immunomodulatory and anticancer effects on Sarcoma-180-bearing mouse model. In vivo injection of proteoglycans to Sarcoma-180-bearing mice decreased the number of tumor cells and cell cycle analysis showed that most of the cells were found to be arrested in pre-G(0)/G(1) phase of cell cycle. All of the three proteoglycans elevated mouse natural killer (NK) cell cytotoxicity and stimulated macrophages to produce nitric oxide. The Fourier transform infra red (FTIR) spectra suggested the presence of beta-glycosidic bond in all the fractions. Fraction I strongly interacted with glucose/mannose-specific lectin Concanavalin A (ConA), indicating the presence of large number of terminal sugar with glucose/mannose. Thus, the three neutral proteoglycans derived from the mushroom (P. ostreatus) mycelia could be used as immunomodulators and anti cancer agents.
Subject(s)
Antineoplastic Agents/therapeutic use , Pleurotus/chemistry , Proteoglycans/therapeutic use , Sarcoma 180/drug therapy , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/immunology , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Chemical Fractionation/methods , Cytotoxicity Tests, Immunologic , Dose-Response Relationship, Drug , Killer Cells, Natural/cytology , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , L-Lactate Dehydrogenase/analysis , Lectins/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Mice , Mycelium/chemistry , Nitric Oxide/metabolism , Protein Binding , Proteoglycans/isolation & purification , Proteoglycans/metabolism , Sarcoma 180/immunology , Sarcoma 180/pathology , Solubility , Spleen/cytology , Spleen/drug effectsABSTRACT
In this study, the fraction (P) from an aqueous extract of dried rose (Rosa rugosa) flowers was obtained by ethanol precipitation. P was chromatographed on DEAE-cellulose. The components retained on DEAE-cellulose were eluted with a linear gradient of 0-2 M NaCl solution. Two fractions, eluted at concentrations of 0.5 M NaCl and 1 M NaCl, respectively, were obtained. These two components were designated as P1 and P2, respectively. P1 was further purified using gel filtration on Sephadex G-200. P(1) yielded two peaks, and the two components were designated as P(1-a) and P(1-b), respectively. P(1-a) was a polysaccharide-peptide complex, and P(1-b) exhibited chemical properties of a condensed tannin as revealed by FTIR and NMR assay of carbohydrate and protein contents and HPLC-ESI-MS. The molecular masses of P(1-a) and P(1-b) were 150 kDa and 8 kDa, respectively. Both P(1-a) and P(1-b) possessed antioxidant activity, with the activity of P(1-b) higher than that of P(1-a). This study demonstrated that different components from rose flowers exhibited antioxidant activity.
Subject(s)
Antioxidants/isolation & purification , Proteoglycans/isolation & purification , Rosa , Tannins/isolation & purification , Animals , Antioxidants/pharmacology , Brain/drug effects , Brain/metabolism , Flowers , Kidney/drug effects , Kidney/metabolism , Male , Mice , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Proteoglycans/pharmacology , Tannins/pharmacologyABSTRACT
A bioactive fraction (GLPG) was extracted and purified from the mycelia of Ganoderma lucidum by EtOH precipitation and DEAE-cellulose column chromatography. GLPG was a proteoglycan and had a carbohydrate:protein ratio of 10.4:1. Its antiviral activities against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) were investigated by the cytopathic effect (CPE) inhibition assay in cell culture. This kind of polysaccharide inhibited the development of the cytopathic effect in dose-dependent manner in HSV-infected cells, moreover did not show any cytotoxic effects on cells even when a concentration was as high as 2000 microg/ml. In order to study the possible mode of action of the antiviral activity of GLPG, cells were treated with GLPG before, during and after infection, and the viral titers in the supernatant of cell culture 48 h post-infection were tested by TCID(50) assay. The antiviral effects in pre-treated and treated during virus infection with GLPG were more remarkable than the treatment of post-infection. Although the precise mechanism has yet to be defined, our work suggested that GLPG inhibits viral replication by interfering with the early events of viral adsorption and entry into target cells. Thus, this proteoglycan seems to be a potential candidate for anti-HSV agents.
Subject(s)
Antiviral Agents/pharmacology , Mycelium , Proteoglycans/pharmacology , Reishi , Animals , Antiviral Agents/isolation & purification , Chlorocebus aethiops , Herpesvirus 1, Human/drug effects , Herpesvirus 1, Human/physiology , Herpesvirus 2, Human/drug effects , Herpesvirus 2, Human/physiology , Mycelium/isolation & purification , Proteoglycans/isolation & purification , Reishi/isolation & purification , Vero CellsABSTRACT
AIM: To investigate the antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide (GLPP). METHODS: Antitumor effect of GLPP was observed in tumor-bearing mice in vivo. At the same time, the effects of GLPP on proliferation of tumor cells and human umbilical cord vascular endothelial cell (HUVEC) were detected by MTT assay in vitro. Subsequently, spleen lymphocytes proliferation of nude mice was stimulated by LPS or ConA. To investigate the anti-angiogenic effect of GLPP, GLPP 80 microg per disc and GLPP-treated serum 10 microL per disc were added to the chick chorioallantoic membrane (CAM) respectively in vivo. RESULTS: GLPP 50, 100, and 200 mg/kg inhibited growth of Sarcoma 180 in BALB/c mice markedly by 35.2 %, 45.2 %, and 61.9 %, respectively. GLPP which was directly added to the cultured medium did not inhibit PG cell proliferation in vitro; but GLPP-treated serum 50, 100, 200 mg/kg potently inhibited PG cell proliferation by 22.5 %, 26.8 %, and 30.3 %, respectively; and reduced the xenograft (human lung carcinoma cell PG) in BALB/c nude mice greatly in vivo by 55.5 %, 46.0 %, and 46.8 %, respectively. Lymphocytes proliferation of nude mice could be stimulated by LPS 5 mg/L but not by ConA 2.5 mg/L, indicating that GLPP could not promote the T lymphocyte proliferation and neutral red phagocytosis of peritoneal macrophages of nude mice. The CAM assay showed that GLPP and GLPP-treated serum had anti-angiogenic effect. GLPP (1, 10, and 100 mg/L) inhibited HUVEC proliferation in vitro with the inhibitory rate of 9.4 %, 15.6 %, and 40.4 %, respectively. CONCLUSION: GLPP has antitumor and anti-angiogenic activity. The anti-angiogenesis of GLPP may be a new mechanism underlying its anti-tumor effects.
Subject(s)
Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Neovascularization, Pathologic , Proteoglycans/pharmacology , Reishi , Sarcoma 180/pathology , Animals , Carcinoma, Squamous Cell/pathology , Cell Division/drug effects , Cell Line, Tumor , Chick Embryo , Chorion/blood supply , Humans , Lung Neoplasms/pathology , Macrophages, Peritoneal , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Phagocytosis/drug effects , Plants, Medicinal/chemistry , Proteoglycans/isolation & purification , Reishi/chemistryABSTRACT
Medicinal mushrooms are increasingly used to treat a wide variety of disease processes. Aqueous extract from the fruiting body or mycelia of Phellinus linteus has been reported to produce antitumor and immunomodulatory activities in vivo and in vitro. However, the therapeutic mechanism has not been known. In the present study, we investigated whether proteoglycan (PL) isolated from P. linteus has an effect on the immunomodulatory activities of the murine splenic lymphocytes (MSLs). Treatment with PL caused a four-fold augmentation in [3H]thymidine incorporation compared to untreated control group in MSLs. Flow cytometric analysis indicated that the affected cell population was mainly CD19(+) cells, but not CD3(+) cells. These data suggested that the main target of PL was the B cells, but not T cells. PL also enhanced the expression of co-stimulatory molecules, CD80 and CD86, in murine B cells in a time-dependent manner. Accordingly, we investigated if intracellular [Ca(2+)] and reactive oxygen intermediates (ROI) were the principal downstream components that contributed to PL-induced activation, with respect to both increases of proliferation and induction of co-stimulatory molecules. However, PL has no influence on the [Ca(2+)] concentration and the ROI formation in murine B cells, whereas the genistein, protein tyrosine kinase (PTK) inhibitor or staurosporine, protein kinase C (PKC), blocked the proliferation and the induction of co-stimulatory molecules, CD80 and CD86, in B cells stimulated with PL. Taken together, these data suggest that PL is a biological response modifier that stimulates proliferation and expression of co-stimulatory molecules in B cells, probably by regulating PTK and PKC signaling pathways.
Subject(s)
B-Lymphocyte Subsets/drug effects , Basidiomycota/chemistry , Immunologic Factors/pharmacology , Lymphocyte Activation/drug effects , Plants, Medicinal/chemistry , Protein Kinase C/physiology , Protein-Tyrosine Kinases/physiology , Proteoglycans/pharmacology , Animals , Antigens, CD/biosynthesis , Antigens, CD19/analysis , B-Lymphocyte Subsets/enzymology , B7-1 Antigen/biosynthesis , B7-2 Antigen , CD3 Complex/analysis , Calcium Signaling , DNA Replication/drug effects , Drug Evaluation, Preclinical , Enzyme Inhibitors/pharmacology , Female , Genistein/pharmacology , Immunologic Factors/isolation & purification , Lymphocyte Activation/physiology , Membrane Glycoproteins/biosynthesis , Mice , Mice, Inbred C57BL , Phosphorylation/drug effects , Protein Kinase C/antagonists & inhibitors , Protein Processing, Post-Translational/drug effects , Protein-Tyrosine Kinases/antagonists & inhibitors , Proteoglycans/isolation & purification , Reactive Oxygen Species , Signal Transduction/drug effects , Staurosporine/pharmacologyABSTRACT
To examine whether oral administration of proteoglycan derived from Phellinus linteus, which is known as the medicinal mushroom, can prevent or treat collagen-induced arthritis (CIA) in mice as experimental model of autoimmune disease. CIA was induced by intradermal injection of type II collagen (CII) emulsified with complete freund's adjuvant (CFA) into the base of the tail (on day 7) followed by a booster injection on day 21 into the footpad. To examine the ability of proteoglycan to effect the inhibition of CIA, doses of proteoglycan were orally administered on day 0 (pre-administration) or day 28 (post-administration) at two groups. The inhibition of CIA by oral administration of proteoglycan was associated with decrease in anti-CII IgG and IgG2a antibodies (Abs) as well as varying kinds of cytokines including IL-12, TNF-alpha, and IFN-gamma. The results showed that administration of proteoglycan was followed by decrease of CIA of the mice in pre- and post-administration groups. Our findings suggest that immunomodulating proteoglycan isolated from P. linteus may be crucially involved in the prevention and treatment of autoimmune joint inflammation such as rheumatoid arthritis, although no definite role of anti-CII Abs in the human disease has been established.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Arthritis, Experimental/drug therapy , Arthritis, Experimental/prevention & control , Basidiomycota/chemistry , Proteoglycans/therapeutic use , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/isolation & purification , Administration, Oral , Animals , Arthritis, Experimental/immunology , Collagen Type II/immunology , Cytokines/biosynthesis , Cytokines/genetics , Enzyme-Linked Immunosorbent Assay , Freund's Adjuvant/immunology , Gene Expression/drug effects , Immunization , Immunoglobulin G/immunology , Isoantibodies/biosynthesis , Isoantibodies/immunology , Male , Mice , Mice, Inbred DBA , Proteoglycans/administration & dosage , Proteoglycans/isolation & purification , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
AIM: To study the antioxidant effect of Ganoderma polysaccharide peptide (GLPP) and its mechanism. METHODS: Copper was used as oxidant to induce low lipoprotein (LDL) oxidative modification, and alloxan was given i.v. to induce reactive oxygen species (ROS) injury in mice. RESULTS: GLPP decreased oxidation of LDL and the relative electrophoretic mobility (REM) of oxidative product of LDL. After GLPP was given i.p. for 20 days, the concentration of malondialdehyde(MDA) in serum and heart of mice was decreased. The GSHpx enzyme activity was increased, while the SOD level was decreased. The catalase(CAT) levels were not significantly changed by GLPP. CONCLUSION: GLPP showed antioxidant effect by scavenging ROS or enhancing the enzyme activity of GSHpx in vivo and in vitro.
Subject(s)
Antioxidants/pharmacology , Glutathione Peroxidase/metabolism , Proteoglycans/pharmacology , Reishi/chemistry , Animals , Antioxidants/isolation & purification , Lipoproteins, LDL/metabolism , Male , Malondialdehyde/blood , Malondialdehyde/metabolism , Mice , Myocardium/metabolism , Oxidation-Reduction/drug effects , Plants, Medicinal/chemistry , Proteoglycans/isolation & purification , Random Allocation , Superoxide Dismutase/metabolismABSTRACT
Isolated protein preparations of the small leucine-rich proteoglycans (SLRPs) associated with mineralized tissues have provided important information in understanding their structural and functional interactions within extracellular matrices and their potential roles in mineralization. Two important SLRPs, decorin and biglycan, copurify following extraction and purification from mineralized tissues using standard procedures, and to overcome this problem decorin was synthesized within a mammalian expression system to obtain pure preparations. The expressed protein was purified from the culture medium using anion-exchange chromatography, and characterization confirmed the presence of a decorin-rich fraction. However, N-terminal sequencing revealed the additional presence of alpha2HS-glycoprotein (alpha2HSG), representing approximately 35% of the total purified fraction. The decorin-rich fraction was subjected to selected further purification techniques to separate decorin from alpha2HSG. Application of the sample at a low concentration (1 mg/ml) to a second anion-exchange procedure and elution over an expanded sodium chloride gradient resulted in a high degree of purity (98%), with a single protein isolate demonstrable by SDS-PAGE. Electroelution achieved partial purification ( approximately 89%), but immunoprecipitation with antibodies against the glycosaminoglycan chain and the polyhistidine tag failed to separate the two proteins. This study suggests there is a strong interaction between recombinantly produced decorin and alpha2 HSG and highlights the importance of the purification technique to the application of recombinantly produced proteins or those that have been extracted from mineralized tissues for use in structural and functional interactions.